Ignite Creation Date:
2024-05-05 @ 11:48 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00137982
Status:
UNKNOWN
Last Update Posted:
2006-09-08
First Post:
2005-08-29
Brief Title:
Evaluation of Therapeutic Strategies for Treatment of Ectopic Pregnancies EP and Evaluation of Subsequent Fertility
Sponsor:
Hopital Antoine Beclere
Organization:
Hopital Antoine Beclere
Study Overview
Official Title:
Prospective Study Randomized Controlled Trial Between Medical Treatment by Methotrexate Versus Conservative Surgical Treatment Group 1 and Conservative Versus Radical Surgical Treatment Group 2 to Evaluate Subsequent Fertility
Status:
UNKNOWN
Status Verified Date:
2005-08
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Three protocols are used to treat ectopic pregnancies medical treatment by methotrexate conservative surgery or radical surgery There are no data about subsequent fertility except in a cohort study The investigators propose to evaluate the true subsequent fertility with a follow-up of 2 years in a randomized controlled trial
Detailed Description:
The first group includes non active ectopic pregnancies defined by score or algorithm In this case we propose a randomized controlled trial between medical and conservative surgery In all others clinical situations we proposed surgery treatment In a randomized controlled trial we compare conservative versus radical treatment The patients are followed-up during 2 years with phone contact every 6 months
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None